Michael J. Bohanon

Tipranavir (PNU-140690):  A Potent, Orally Bioavailable Nonpeptidic HIV Protease Inhibitor of the 5,6-Dihydro-4-hydroxy-2-pyrone Sulfonamide Class

Steve R. Turner, Joseph W. Strohbach, Rubén Tommasi et al. · Journal of Medicinal Chemistry · 1998 · 293 citations · Full text

Discovery, SAR, and Pharmacokinetics of a Novel 3-Hydroxyquinolin-2(1<i>H</i>)-one Series of Potent<scp>d</scp>-Amino Acid Oxidase (DAAO) Inhibitors

Allen J. Duplantier, Stacey L. Becker, Michael J. Bohanon et al. · Journal of Medicinal Chemistry · 2009 · 109 citations · Full text

3-Arylpiperidines as potentiators of existing antibacterial agents

Atli Thorarensen, Alice L. Presley‐Bodnar, Keith R. Marotti et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 56 citations · Full text

Antibacterial Agents, Medicinal Chemistry, Antibiotics +10

Localization of Separate Genetic Loci for Reduced Sensitivity towards Small Isometric-Headed Bacteriophage sk1 and Prolate-Headed Bacteriophage c2 on pGBK17 from <i>Lactococcus lactis</i> subsp. <i>lactis</i> KR2

Larry L. McKay, Michael J. Bohanon, Kayla M. Polzin et al. · Applied and Environmental Microbiology · 1989 · 35 citations · Full text

Identification of novel potent hydroxamic acid inhibitors of peptidyl deformylase and the importance of the hydroxamic acid functionality on inhibition

Atli Thorarensen, Martin R. Douglas, Douglas C. Rohrer et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 29 citations · Full text

Medicinal Chemistry, Bioorganic Chemistry, Biochemistry +12